Stay updated on Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedRecent updates to the Study Record Dates include a new last update on 2026-08-03 and related QC/submission dates (2026-07-30, 2026-07), while older 2023 timestamps were removed, indicating updated record-keeping for the study's status.SummaryDifference0.2%

- Check14 days agoChange DetectedRevision: v3.6.4 on the page indicates a new software version has been deployed, replacing v3.6.3. This is an internal update of the site rather than a change to the study information presented.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, representing a small software/content update to the page.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a new build of the study details page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now states that enrollment is closed (no longer looking for participants) and adds new user-guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study; the older Intervention / Treatment heading and the Revision: v3.5.5 tag were removed.SummaryDifference0.5%

- Check64 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, reflecting a minor update to the page’s rendering/versioning.SummaryDifference0.1%

Stay in the know with updates to Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.